Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederglobenewswire.com
GlobeNewswire - Industry News on Pharmaceuticals
Get the latest updates from GlobeNewswire - Industry News on Pharmaceuticals directly as they happen.
Follow now 122 followers
Latest posts
Last updated about 24 hours ago
Biotech startup Plopii Files US Patent on the Next-Generation Headache Pill
about 24 hours ago
Brooklyn biotech files 40-claim patent application covering a new active-ingredient combination for...
Communiqué de presse : Sanofi place 2,3 milliard d’euros d’emprunts obligataires
about 24 hours ago
Sanofi place 2,3 milliard d’euros d’emprunts obligataires
Press Release: Sanofi successfully prices 2.3 billion of bond issue
about 24 hours ago
Sanofi successfully prices 2.3 billion of bond issue
Financière de Tubize - Goedkeuring van het dividend
1 day ago
Goedkeuring van het dividendGereglementeerde informatie - 24 april 2026
Financière de Tubize - Approbation du dividende
1 day ago
Approbation du dividendeInformation réglementée - 24 avril 2026
Financière de Tubize - Dividend approval
1 day ago
Dividend confirmationRegulated information - 24 April 2026
Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026
1 day ago
NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX)...
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET
1 day ago
PRINCETON, N.J., April 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI...
Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)
1 day ago
Basel, April 24, 2026 – Novartis today announced that the Committee for...
Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
1 day ago
Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat...
Communiqué de presse : Cenrifki de Sanofi (tolebrutinib) recommandé par le Comité des médicaments à usage humain (CMUH) pour être approuvé par l’UE pour le traitement de la sclérose en plaques secondairement progressive sans poussées
1 day ago
Cenrifki de Sanofi (tolebrutinib) recommandé par le Comité des médicaments à usage...